• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL1300223 GSK573719 umeclidinium bromide Other Chemical Drugs Import Drug Application 2013-08-02 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2015-02-12 view
JXHL1100183 GSK573719/GW642444 umeclidinium bromide;vilanterol Other Chemical Drugs Import Drug Application 2011-06-09 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2012-03-15 view
JXHL1200024 GSK573719/GW642444 umeclidinium bromide;vilanterol Other Chemical Drugs Import Drug Application 2012-02-09 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2012-06-14 view
JYHB2300304 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2023-05-24 view
JXHL2000355 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2021-01-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-01-04 view
JYHZ2400073 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) License Renew 2024-03-26 view
JYHB2200313 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2022-06-21 view
JYHB2001496 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2020-08-20 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Filed 2020-08-31 view
JTH2400035 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs Disposable Import Drug Application 2024-03-04 view
JYHB2000236 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs Supplementary Application 2020-03-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2020-06-19 view
JYHB2400111 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-03-02 view
JYHB2002759 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2021-01-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-01-04 view
JYHB2400459 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2024-08-20 view
JYHB2300730 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Supplementary Application 2023-12-19 view
JXHL2000354 氟替美维吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2021-01-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-01-04 view
JXHL1400135 糠酸氟替卡松/溴化Umeclidinium/三苯乙酸维兰特罗(GW685698/ GSK573719/ GW642444)吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs Import Drug Application 2014-04-23 Glaxo Group Limited. Glaxo Group Ltd Certificate Issued 2015-05-28 view
JXHL1400053 糠酸氟替卡松/溴化Umeclidinium/三苯乙酸维兰特罗(GW685698/ GSK573719/ GW642444)吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs Import Drug Application 2014-02-26 Glaxo Group Limited. Glaxo Group Ltd Certificate Issued 2015-05-28 view
JXHS1800025 糠酸氟替卡松乌美溴铵维兰特罗吸入粉雾剂 fluticasone furoate;umeclidinium bromide;vilanterol Powder for inhalation Chemical Drugs(5.1) Import Drug Application 2018-06-28 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2019-11-08 view